Preparation and in vitro/pharmacokinetic/pharmacodynamic evaluation of a slow-release nano-liposomal form of prednisolone

References

• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliver Rev 65:36–48
   PubMed Web of Science ®Google Scholar
• Banciu M, Metselaar JM, Schiffelers RM, Storm G. (2008). Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. Neoplasia 10:108–17
   PubMed Web of Science ®Google Scholar
• Banciu M, Schiffelers RM, Fens MH, et al. (2006). Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice. J Control Release 113:1–8
   PubMed Web of Science ®Google Scholar
• Czock D, Keller F, Rasche FM, Häussler U. (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44:61–98
   PubMed Web of Science ®Google Scholar
• De Bosscher K, Haegeman G. (2009). Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol Endocrinol 23:281–91
   PubMed Web of Science ®Google Scholar
• Dési E, Kovács Á, Palotai Z, Kende A. (2008). Analysis of dexamethasone and prednisolone residues in bovine milk using matrix solid phase dispersion-liquid chromatography with ultraviolet detection. Microchem J 89:77–81
   Web of Science ®Google Scholar
• Fatouros DG, Antimisiaris SG. (2002). Effect of amphiphilic drugs on the stability and zeta-potential of their liposome formulations: a study with prednisolone, diazepam, and griseofulvin. J Colloid Interf Sci 251:271–7
   PubMed Web of Science ®Google Scholar
• Gaafar PM, Abdallah OY, Farid RM, Abdelkader H. (2014). Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone. J Liposome Res 24:204–15
   PubMed Web of Science ®Google Scholar
• Hofkens W, Schelbergen R, Storm G, et al. (2013). Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation PLoS One 8:e54016
   Google Scholar
• Hofkens W, Van Den Hoven JM, Pesman GJ, et al. (2011). Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide. Int J Pharm 416:493–8
   PubMed Web of Science ®Google Scholar
• Karn PR, Jin SE, Lee BJ, et al. (2014). Preparation and evaluation of cyclosporin a-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method. Int J Nanomedicine 9:5079
   PubMed Web of Science ®Google Scholar
• Leroy C, Rigot JM, Leroy M, et al. (2015). Immunosuppressive drugs and fertility. Orphanet J Rare Disease 10:136
   PubMed Web of Science ®Google Scholar
• Liao J, Hayashi K, Horikoshi S, et al. (2001). Effect of steroid-liposome on immunohistopathology of IgA nephropathy in ddY mice. Nephron 89:194–200
   PubMed Web of Science ®Google Scholar
• Lobatto ME, Calcagno C, Otten MJ, et al. (2015). Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy. Nanomedicine 11:1133–40
   PubMed Web of Science ®Google Scholar
• Malaekeh‐Nikouei B, Ghaeni FA, Motamedshariaty VS, Mohajeri SA. (2012). Controlled release of prednisolone acetate from molecularly imprinted hydrogel contact lenses. J Appl Polym Sci 126:387–94
   Web of Science ®Google Scholar
• Mcdonough AK, Curtis JR, Saag KG. (2008). The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 20:131–7
   PubMed Web of Science ®Google Scholar
• Metselaar J, Van Den Berg W, Holthuysen A, et al. (2004). Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis 63:348–535
   PubMed Web of Science ®Google Scholar
• Metselaar JM, Wauben MH, Wagenaar, et al. (2003). Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. . Arthritis Rheum 48:2059–66
   PubMed Web of Science ®Google Scholar
• Meure LA, Foster NR, Dehghani F. (2008). Conventional and dense gas techniques for the production of liposomes: a review. AAPS PharmSciTech 9:798–809
   PubMed Web of Science ®Google Scholar
• Mishina EV, Binder J, Kupiec-Weglinski JW, Jusko WJ. (1994). Effect of liposomal methylprednisolone on heart allograft survival and immune function in rats. J Pharmacol Exp Ther 271:868–74
   PubMed Web of Science ®Google Scholar
• Needham D, Ponce A. (2002). Nanoscale drug delivery vehicles for solid tumors, nanotechnology for cancer therapy. CRC Press, Taylor & Francis, 677–719
   Google Scholar
• Ozbakir B, Crielaard BJ, Metselaar JM, et al. (2014). Liposomal corticosteroids for the treatment of inflammatory disorders and cancer. J Control Release 190:624–36
   PubMed Web of Science ®Google Scholar
• Paliwal SR, Paliwal R, Vyas SP. (2015). A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery. Drug Deliv 22:231–42
   PubMed Web of Science ®Google Scholar
• Saag KG. (2002). Glucocorticoid use in rheumatoid arthritis. Curr Rheumatol Rep 4:218–25
   PubMedGoogle Scholar
• Samad A, Sultana Y, Aqil M. (2007). Liposomal drug delivery systems: an update review. Curr Drug Deliv 4:297–305
   PubMedGoogle Scholar
• Schiffelers RM, Banciu M, Metselaar JM, Storm G. (2006). Therapeutic application of long-circulating liposomal glucocorticoids in auto-immune diseases and cancer. J Liposome Res 16:185–94
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Metselaar JM, Fens MH, et al. (2005). Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. Neoplasia 7:118–27
   PubMed Web of Science ®Google Scholar
• Schmidt J, Metselaar JM, Wauben MH, et al. (2003). Drug targeting by long‐circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain 126:1895–904
   PubMed Web of Science ®Google Scholar
• Ticehurst M, York P, Rowe R, Dwivedi S. (1996). Characterisation of the surface properties of α-lactose monohydrate with inverse gas chromatography, used to detect batch variation. Int J Pharm 141:93–9
   Web of Science ®Google Scholar
• Van Den Hoven JM, Hofkens W, Wauben MH, et al. (2011). Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis. Int J Pharm 416:471–7
   PubMed Web of Science ®Google Scholar
• Van Der Geest T, Metselaar JM, Gerrits D, et al. (2015). FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis. J Control Release 209:20–6
   PubMed Web of Science ®Google Scholar
• Van Der Valk FM, Van Wijk DF, Lobatto ME, et al. (2015). Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. Nanomedicine 11:1039–46
   PubMed Web of Science ®Google Scholar
• Wang F, Yang Z, Zhou Y, et al. (2006). Influence of metal ions on phosphatidylcholine–bovine serum albumin model membrane, an FTIR study. J Mol Struct 794:1–11
   Web of Science ®Google Scholar
• Waynforth HB, Flecknell PA. (1980). Experimental and surgical technique in the rat. London: Academic press
   Google Scholar
• Zakeri-Milani P, Nezhadi SH, Barzegar-Jalali M, et al. (2011). Studies on dissolution enhancement of prednisolone, a poorly water-soluble drug by solid dispersion technique. Adv Pharm Bull 1:48
   PubMedGoogle Scholar
• Zuidam N, Van Winden E, De Vrueh R, Crommelin D. (2003). Stability, stage, and sterilization of liposomes. In: Liposomes. Oxford: Oxford University Press, 149–65
   Google Scholar